Skip to main content

Table 1 Demographic and clinical characteristics

From: NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort

 

Survived (n=832)

Died (n=146)

p-value

Demographic characteristics,

 Age (years), median (IQR)

72 (62–80)

82 (78–83)

< 2.20×10−16

 Female sex, n (%)

278 (33.4)

67 (45.9)

4.86×10−03

Cardiovascular risk factors, n (%)

 Hypertension

537 (64.5)

104 (71.2)

1.21×10−01

 Dyslipidemia

294 (35.3)

32 (21.9)

3.55×10−03

 Current smokers

226 (27.2)

20 (13.7)

1.45×10−04

 Ex-smokers

21 (2.5)

8 (5.5)

4.01×10−01

 CAD

220 (26.4)

17 (11.6)

5.03×10−04

 Diabetes

197 (23.7)

61 (41.8)

6.32×10−06

Medical history, n (%)

 Myocardial infarction

164 (19.7)

48 (32.9)

5.23×10−04

 Angina, onset > 1 month

119 (14.3)

24 (16.4)

8.96×10−01

 Angina, onset ≤ 1 month

149 (17.9)

15 (10.3)

3.78×10−02

 CABG

41 (4.9)

10 (6.8)

4.39×10−01

 PCI

136 (16.3)

32 (21.9)

1.20×10−01

 Chronic heart failure

33 (4.0)

26 (17.8)

2.62×10−10

 Atrial fibrillation

42 (5.0)

21 (14.4)

4.60×10−05

 Cerebrovascular disease

50 (6.0)

28 (19.2)

1.28×10−07

Presentation features

 ACS classification, STEMI, n (%)

343 (41.2)

35 (24.0)

1.15×10−04

 Killip II–IV, n (%)

114 (13.7)

61 (41.8)

6.33×10−16

 Creatinine > 1.2 mg/dL, n (%)

129 (15.5)

54 (37.0)

4.08×10−09

 Heart rate (bpm), median (IQR)

80 (67–91)

90 (80–105)

3.66×10−06

 Positive peak troponine maximum, n (%)

804 (96.6)

143 (97.9)

6.98×10−01

 Positive peak CK-MB maximum, n (%)

422 (50.7)

50 (32.2)

1.88×10−03

 GRACE score > 118, n (%)

687 (82.6)

123 (84.2)

1.62×10−01

  1. CAD coronary artery diseases, CABG coronary artery bypass grafting, PCI percutaneous coronary intervention, ACS acute coronary syndrome, STEMI ST-segment elevation myocardial infarction, CK-MB creatine kinase-MB, GRACE Global Registry of Acute Coronary Events